(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 5. Defective subepicardial mesenchyme development in
Smomlc2v CKO hearts. (A-F) Immunofluorescent
staining for cardiac actin (B,E; green) and PECAM (A,D; red), confirming that
although control hearts (A-C) contain both subepicardial (white arrowhead) and
intramyocardial (white arrow) blood vessels, Smomlc2v CKO
hearts (D-F) contain only blood vessels growing within the myocardial wall
(yellow arrow). (A,B,D,E) Fluorescent signals are superimposed on DIC images
for orientation. (C,F) Merge of fluorescent signals in A,B and D,E,
respectively. Red arrowheads in B,E denote position of subepicardial
mesenchyme. (G-J) Immunofluorescent staining for PECAM (G,I; red),
cardiac actin (G-J; green), WT1 (H,J; red) and DAPI (H,J; blue) demonstrating
that compared with control hearts (G,H) that contain well-developed
subepicardial mesenchyme (denoted by white arrowheads, H),
Smomlc2v CKO hearts (I,J) contain only blood vessels
growing within the myocardial wall (yellow arrow) and fail to develop
subepicardial mesenchyme (white arrowheads, J).